Pharmacoeconomic analysis of Actemra^® in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy

Rheumatoid arthritis (RA) is a severe, autoimmune disorder characterized by relatively high prevalence among working-age adult population, significant quality of life and work performance impact, as well as high risk of complete disability in case of inadequate or ineffective treatment. The creation...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
Materyal Türü:	Artigo
Dil:	Russo
Baskı/Yayın Bilgisi:	Izdatelstvo OKI 2018-05-01
Seri Bilgileri:	Качественная клиническая практика
Konular:	ревматоидный артрит тоцилизумаб адалимумаб фармакоэкономика анализ эффективности затрат анализ влияния на бюджет rheumatoid arthritis tocilizumab adalimumab pharmacoeconomics cost-effectiveness analysis budget impact analysis
Online Erişim:	https://www.clinvest.ru/jour/article/view/54
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!